Piramal Pharma (NSE:PPLPHARMA) EBIT per Share : ₹4.91 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma EBIT per Share?

Piramal Pharma's EBIT per Share for the three months ended in Mar. 2024 was ₹2.63. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹4.91.

During the past 3 years, the average EBIT per Share Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Piramal Pharma's EBIT per Share or its related term are showing as below:

NSE:PPLPHARMA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -3.2 Med: -3.2 Max: -3.2
Current: -3.2

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Piramal Pharma was -3.20% per year. The lowest was -3.20% per year. And the median was -3.20% per year.

NSE:PPLPHARMA's 3-Year EBIT Growth Rate is ranked worse than
67.52% of 859 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs NSE:PPLPHARMA: -3.20

Piramal Pharma's EBIT for the three months ended in Mar. 2024 was ₹3,417 Mil.

Piramal Pharma EBIT per Share Historical Data

The historical data trend for Piramal Pharma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma EBIT per Share Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

EBIT per Share

3.95

5.54

1.85

4.93

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial							1.66	0.09	1.19	0.99	2.63

Piramal Pharma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Piramal Pharma's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	6277.8	/	1272.857
=	4.93

Piramal Pharma's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3417	/	1298.247
=	2.63

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.91

Piramal Pharma (NSE:PPLPHARMA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Piramal Pharma EBIT per Share Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » EBIT per Share

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines